CME Group, Inc. (CME) Misses Q1 EPS by 2c
CME Group, Inc. (NASDAQ: CME) reported Q1 EPS of $0.71, $0.02 worse than the analyst estimate of $0.73. Revenue for the quarter came in at $719 million versus the consensus estimate of $711.88 million.
"We have made progress so far this year as we continue to implement our global strategy," said CME Group Executive Chairman and President Terry Duffy. "Our overall average daily volume was 12.5 million in the first quarter compared with 10.5 million in the second half of last year, driven by strength in our interest rate, foreign exchange and equity products. As the over-the-counter market transitions, we are providing our clients with a variety of tools to help them manage risk. Looking ahead, we will keep investing in the company's growth while also continuing to consistently return capital to shareholders in the most efficient way."
"Our focus on expense discipline during the first quarter equated to stronger operating leverage," said CME Group Chief Executive Officer Phupinder Gill. "At the same time, we are expanding our European presence with the anticipated launch of our European exchange this summer, along with new products to the CME Clearing Europe slate, such as the recently launched interest rate swaps. We also posted record trading volume and revenue from Asia, up 24 percent and 31 percent, respectively. Additionally, we are working with hundreds of customers and many intermediaries to ensure operational readiness ahead of the second wave of the OTC clearing mandate that will take place June 10."
For earnings history and earnings-related data on CME Group, Inc. (CME) click here.
"We have made progress so far this year as we continue to implement our global strategy," said CME Group Executive Chairman and President Terry Duffy. "Our overall average daily volume was 12.5 million in the first quarter compared with 10.5 million in the second half of last year, driven by strength in our interest rate, foreign exchange and equity products. As the over-the-counter market transitions, we are providing our clients with a variety of tools to help them manage risk. Looking ahead, we will keep investing in the company's growth while also continuing to consistently return capital to shareholders in the most efficient way."
"Our focus on expense discipline during the first quarter equated to stronger operating leverage," said CME Group Chief Executive Officer Phupinder Gill. "At the same time, we are expanding our European presence with the anticipated launch of our European exchange this summer, along with new products to the CME Clearing Europe slate, such as the recently launched interest rate swaps. We also posted record trading volume and revenue from Asia, up 24 percent and 31 percent, respectively. Additionally, we are working with hundreds of customers and many intermediaries to ensure operational readiness ahead of the second wave of the OTC clearing mandate that will take place June 10."
For earnings history and earnings-related data on CME Group, Inc. (CME) click here.